Iovance Biotherapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell IOVA and other ETFs, options, and stocks.

About IOVA

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). 

CEO
Frederick G. Vogt
CEOFrederick G. Vogt
Employees
975
Employees975
Headquarters
San Carlos, California
HeadquartersSan Carlos, California
Founded
2007
Founded2007
Employees
975
Employees975

IOVA Key Statistics

Market cap
4.97B
Market cap4.97B
Price-Earnings ratio
-15.24
Price-Earnings ratio-15.24
Dividend yield
—
Dividend yield—
Average volume
15.98M
Average volume15.98M
High today
$11.17
High today$11.17
Low today
$10.68
Low today$10.68
Open price
$10.90
Open price$10.90
Volume
12.23M
Volume12.23M
52 Week high
$11.17
52 Week high$11.17
52 Week low
$1.76
52 Week low$1.76

Stock Snapshot

The current Iovance Biotherapeutics(IOVA) stock price is $11.04, with a market capitalization of 4.97B. The stock trades at a price-to-earnings (P/E) ratio of -15.24.

As of 2026-09-29, Iovance Biotherapeutics(IOVA) stock has fluctuated between $10.68 and $11.17. The current price stands at $11.04, placing the stock +3.4% above today's low and -1.1% off the high.

Iovance Biotherapeutics(IOVA) shares are trading with a volume of 12.23M, against a daily average of 15.98M.

In the last year, Iovance Biotherapeutics(IOVA) shares hit a 52-week high of $11.17 and a 52-week low of $1.76.

In the last year, Iovance Biotherapeutics(IOVA) shares hit a 52-week high of $11.17 and a 52-week low of $1.76.

IOVA News

Simply Wall St 2d
Iovance Biotherapeutics Stock Trades At A Premium As Shares Jumped 421%

has seen its stock climb sharply over the past year, and that kind of move naturally raises a basic question for anyone looking at the shares. Is the current pr...

Iovance Biotherapeutics Stock Trades At A Premium As Shares Jumped 421%

Analyst ratings

80%

of 10 ratings
Buy
80%
Hold
20%
Sell
0%

People also own

Based on the portfolios of people who own IOVA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.